Shrinking-Core and Shrinking-Sphere Assumptions

Why the assumed particle geometry matters

Dissolution rate depends on the area available for mass transfer. As a particle loses solid, that area usually changes, so holding it constant can distort the predicted rate even when the local dissolution law is otherwise appropriate. A geometric model makes this change explicit—but only if its picture of the particle is credible.

Two useful idealizations describe different physical structures. In a shrinking-sphere model, a homogeneous spherical particle recedes at its outer surface. In a shrinking-core model, a drug-rich core recedes inside a particle whose outer boundary can remain in place, for example because an insoluble or porous shell persists. Their radii may obey the same cube-root relation to remaining drug mass, but the surfaces represented by those radii are not necessarily the same.

Definition: A shrinking sphere is a homogeneous spherical solid whose outer radius decreases as solid dissolves. A shrinking core is a spherical unreacted or undissolved drug region whose radius decreases within a surrounding layer or matrix. The shrinking sphere's area is its exposed dissolving surface; the shrinking core's area is its internal core–shell interface. The particle's external area is a separate quantity when the shell persists.

Geometry and the shrinking-sphere relationship

Let \(r\) be the current radius of a spherical particle and \(\rho\) its constant solid density. Its mass \(M\), volume \(V\), and exposed area \(A\) are

V=\frac{4}{3}\pi r^3,\qquad M=\rho V=\frac{4}{3}\pi\rho r^3,\qquad A=4\pi r^2.

If the initial radius is \(r_0\), then the fraction of initial solid mass remaining is \(M/M_0=(r/r_0)^3\), provided density and composition do not change. Eliminating the radius gives

\frac{r}{r_0}=\left(\frac{M}{M_0}\right)^{1/3},\qquad \frac{A}{A_0}=\left(\frac{r}{r_0}\right)^2 =\left(\frac{M}{M_0}\right)^{2/3}.

Thus area does not decrease in direct proportion to mass: it decreases as the two-thirds power of remaining mass. The geometry alone does not specify the dissolution rate. If \(J\) is the outward mass flux from the surface, in mass per area per time, mass balance gives \(-dM/dt=JA\). Under the additional assumption that \(J\) is constant, differentiating the mass expression and cancelling the common area term yields a constant rate of radius recession:

-\frac{dM}{dt}=J(4\pi r^2),\qquad -\frac{d}{dt}\left(\frac{4}{3}\pi\rho r^3\right)=4\pi r^2J, \qquad \frac{dr}{dt}=-\frac{J}{\rho}.

Consequently, \(r(t)=r_0-(J/\rho)t\) while the particle remains, and the idealized complete-dissolution time is \(\rho r_0/J\). Constant flux is an extra kinetic assumption, not a consequence of spherical shape. If flux changes with time or particle state, the radius–mass–area relationships still apply, but this linear radius-time result does not.

Worked Example: Area After a Quarter of the Particle Mass Dissolves

Consider a hypothetical homogeneous spherical drug particle with initial radius \(100\ \mu\text{m}\). Suppose 25% of its solid mass has dissolved, with density and composition unchanged. Find its remaining radius and exposed area.

The remaining mass fraction is \(0.75\). Therefore,

r=100(0.75)^{1/3}\ \mu\text{m} \approx90.86\ \mu\text{m}.

The initial area is \(A_0=4\pi(100\ \mu\text{m})^2\approx125{,}664\ \mu\text{m}^2\). The area fraction is \(0.75^{2/3}\approx0.82548\), so

A=4\pi(100\ \mu\text{m})^2(0.75)^{2/3} \approx103{,}733\ \mu\text{m}^2.

The particle retains 75% of its mass but about 82.55% of its initial area. The larger area fraction is expected because area scales with the two-thirds power of mass, not directly with mass.

What changes in a shrinking-core model?

Let \(a_0\) be the initial radius of a spherical drug core and \(a\) its current radius. Assume the drug core has constant density and remains spherical. The core mass and its interfacial area are

M_c=\frac{4}{3}\pi\rho_c a^3,\qquad A_{\mathrm{int}}=4\pi a^2,

where \(\rho_c\) is the core density and \(A_{\mathrm{int}}\) is the area of the core–shell interface. Relative to the initial core,

\frac{M_c}{M_{c,0}}=\left(\frac{a}{a_0}\right)^3,\qquad \frac{A_{\mathrm{int}}}{A_{\mathrm{int},0}} =\left(\frac{a}{a_0}\right)^2 =\left(\frac{M_c}{M_{c,0}}\right)^{2/3}.

This relation describes the area of the shrinking core interface, not necessarily the area exposed to the surrounding fluid. For a persistent spherical shell with fixed outer radius \(R\), the external area is \(4\pi R^2\), which stays constant while the interface area \(4\pi a^2\) decreases. The shell thickness is \(R-a\). If the outer boundary itself moves, swells, fragments, or erodes, its area must be specified separately; it cannot be inferred from core mass alone.

The core model also requires a physical interpretation of the interface. Drug must be removed from the core while the surrounding region remains sufficiently intact to define a core boundary. If drug is distributed throughout a matrix rather than concentrated in a distinct core, or if dissolution creates irregular channels instead of a coherent interface, a single core radius may not represent the dissolving structure.

Worked Example: Half the Drug Core Remains

A hypothetical spherical drug core initially has radius \(80\ \mu\text{m}\). Its surrounding shell has fixed outer radius \(100\ \mu\text{m}\). Assume constant core density, a distinct spherical interface, and no change in the shell's outer boundary. Find the core radius, interface area, and external area when half the initial core mass remains.

Since the remaining core mass fraction is \(0.5\), the radius is

a=80(0.5)^{1/3}\ \mu\text{m}\approx63.50\ \mu\text{m}.

The initial core-interface area is \(4\pi(80)^2\approx80{,}425\ \mu\text{m}^2\). Its current area can be calculated from the mass fraction without rounding the radius:

A_{\mathrm{int}}=4\pi(80\ \mu\text{m})^2(0.5)^{2/3} \approx50{,}664\ \mu\text{m}^2.

The external area remains \(4\pi(100\ \mu\text{m})^2\approx125{,}664\ \mu\text{m}^2\), by the stated fixed-outer-radius assumption. The shell thickness has increased from \(100-80=20\ \mu\text{m}\) to approximately \(100-63.50=36.50\ \mu\text{m}\). This example illustrates why a shrinking-core model must keep the reaction interface and external particle surface distinct.

Derivation and assumptions at a glance

Both area laws follow from sphere geometry, rather than from a particular dissolution mechanism. For either a homogeneous sphere or a distinct spherical core, mass is proportional to radius cubed and the corresponding spherical surface is proportional to radius squared. Eliminating the radius therefore gives an area proportional to the two-thirds power of the relevant remaining mass fraction. The difference lies in identifying which mass and which surface are relevant.

Choose the solid region.
For a shrinking sphere, use the homogeneous particle's remaining solid mass. For a shrinking core, use the remaining drug mass in the core.

State the geometry.
Assume a sphere with a well-defined radius and a sufficiently uniform density. For a core–shell particle, also state whether the outer boundary is fixed or changing.

Calculate the relevant area.
Apply \(A=4\pi r^2\) to the shrinking sphere's outer surface or \(A_{\mathrm{int}}=4\pi a^2\) to the shrinking core interface. Do not substitute the shell's outer area for the core interface.

Check structural plausibility.
Compare the assumed boundary with available particle images, size measurements, or formulation knowledge. A geometric equation cannot make a poorly defined physical surface real.

These assumptions are useful approximations, not guarantees. A particle may be nonspherical, rough, porous, internally heterogeneous, or composed of a distribution of sizes. Fracture or erosion can create new surfaces; aggregation can hide surface; swelling can change dimensions without proportional drug loss. In such cases, an equivalent spherical radius inferred from mass is a volume-equivalent measure, and its calculated area need not equal the true wetted or reactive area.

Worked Example: A Cylindrical Particle Is Not a Shrinking Sphere

Consider a hypothetical solid cylinder with radius \(R=50\ \mu\text{m}\) and fixed length \(L=200\ \mu\text{m}\). Suppose it dissolves uniformly from its side, with non-receding end faces, retaining its cylindrical shape, until half its original mass remains. Assume constant density and length. Compare its actual geometric area with the prediction from a shrinking-sphere mass–area relationship.

The cylinder volume is \(\pi r^2L\), so half the mass at unchanged density means \(r^2/R^2=0.5\), or \(r/R=\sqrt{0.5}\approx0.7071\). Its total area, including both end faces, is \(A=2\pi rL+2\pi r^2\). Thus,

\frac{A}{A_0} =\frac{r}{R}\frac{L+r}{L+R} =0.7071\frac{200+35.36}{200+50} \approx0.6657.

The initial area is \(2\pi(50)(200)+2\pi(50)^2=25{,}000\pi\approx78{,}540\ \mu\text{m}^2\). Using the unrounded area ratio and initial area, the cylinder's current area is approximately \(52{,}283\ \mu\text{m}^2\). A shrinking-sphere approximation would instead give an area fraction of \(0.5^{2/3}\approx0.6300\). The difference arises because a fixed-length cylinder changes radius differently from a sphere. Which model is appropriate depends on observed shape and recession, not on which formula is simpler.

Diagnostics, alternatives, and common pitfalls

A geometric area assumption should be questioned if measured particle dimensions do not change in the way its model predicts. For a shrinking sphere, mass loss should correspond to radius proportional to the cube root of remaining mass, with area proportional to radius squared. For a shrinking core, the same relationships should hold for the core dimensions and core mass, while the outer dimensions may follow a different pattern. Persistent disagreement can indicate non-spherical particles, a changing density, shell swelling or erosion, internal porosity, or a measurement that reports an equivalent rather than a physical radius.

A single representative radius can also conceal a broad particle-size distribution: different-sized particles contribute different areas per unit mass. The earlier material on representing particle-size distributions and population-balance models addresses how to track multiple size classes or their evolution. Those approaches are alternatives when one changing radius cannot adequately summarize the powder. A simple shrinking geometry is most defensible for particles with a reasonably consistent shape and a clear, reproducible receding boundary.

Using mass fraction as area fraction. If half the mass remains, the area fraction for a spherical receding surface is \(0.5^{2/3}\approx0.6300\), not \(0.5\).
Confusing internal and external area. A shrinking core's interface may contract even while the shell's external area stays fixed. Identify which surface the dissolution flux is applied to.
Assuming constant flux from constant geometry. Spherical geometry gives the area–mass relation. Linear radius loss over time additionally requires constant flux and density.
Treating an equivalent sphere as an observed sphere. A radius computed from particle volume does not establish that a particle has the sphere's surface area, particularly for rough, elongated, or porous material.
Using the core model without a distinct core. If drug is dispersed throughout a matrix or the interface becomes fragmented, a single core radius and interface area may be physically misleading.

The practical value of these models is not that every drug particle is spherical. It is that they make the consequences of a chosen geometry explicit and testable. When shape or internal structure violates the assumptions, the appropriate response is to revise the representation or use a richer particle description—not to interpret the fitted area as a directly measured surface.

Check Your Understanding

Answer each question using the stated geometry and assumptions. Brief solutions follow.

A spherical particle has 20% of its initial mass remaining. What fraction of its initial radius and area remain?
A shrinking core retains 27% of its initial drug mass. What fraction of its initial core-interface area remains? Does this determine the external area of a fixed-radius shell?
Why does a constant mass flux from a shrinking sphere imply a linearly decreasing radius when density is constant?
A particle's outer radius stays constant while its drug content falls. Which geometric representation might fit, and what additional physical feature should be checked?

Solutions. (1) The radius fraction is \(0.20^{1/3}\approx0.5848\); the area fraction is \(0.20^{2/3}\approx0.3420\). (2) The interface-area fraction is \(0.27^{2/3}=(0.3)^2=0.0900\). Thus 9.00% remains. A fixed shell's external area is set by its outer radius and does not follow from that core-mass fraction. (3) Mass is proportional to \(r^3\) and area to \(r^2\). Substitution into \(-dM/dt=JA\) gives \(-4\pi\rho r^2(dr/dt)=4\pi r^2J\), hence \(dr/dt=-J/\rho\), a constant. (4) A shrinking-core representation may fit if a distinct drug-rich core recedes inside a persistent shell or matrix. Check whether a coherent core–shell interface actually exists and whether the shell remains intact and fixed in size.